Department of Cornea and Refractive Services, The Eye Foundation, Post Graduate Institute of Ophthalmology, Coimbatore, Tamil Nadu, India.
The Eye Foundation, Coimbatore, Tamil Nadu, India.
Indian J Ophthalmol. 2018 Apr;66(4):506-510. doi: 10.4103/ijo.IJO_890_17.
The aim of this study is to describe a modified technique of using conjunctival tissue from the pterygium itself without any rotation of graft for the primary pterygium in eyes with glaucoma filtering bleb, glaucoma suspects, and in primary double-head pterygium using fibrin glue.
In this retrospective, noncomparative, interventional case series, 98 eyes of 98 patients with primary pterygium operated between July 2011 to July 2016 were included. They underwent this technique from the pterygium tissue itself. There was no rotation of this graft, and it was adhered to the bare scleral defect with fibrin glue. Histopathological analysis of pterygium tissue was done to look for morphology and thickness of this thin conjunctival tissue obtained from pterygium tissue itself. The primary outcome measure was recurrence rate. Other outcome measures studied was graft retraction and graft edema.
The mean age was 52 ± 10.04 years. Mean follow-up was 14 ± 8.24 months. The only significant complication was recurrence rate of 4.08% (4 eyes out of 98). The most come secondary outcome was graft edema, 52.04% (51 eyes out of 98) which resolved without any intervention. Other outcome such as graft retraction, 32.65% was also recorded.
Conjunctival tissue from the pterygium tissue itself without actual rotation appears to be a successful technique with lower recurrence rate for treating primary pterygium in eyes with glaucoma filtering bleb, glaucoma suspects, and in primary double-head pterygium.
本研究旨在描述一种改良技术,即使用纤维蛋白胶,从原发性翼状胬肉本身的结膜组织中获取移植物,而无需对青光眼滤过泡、青光眼疑似患者以及原发性双头翼状胬肉进行任何旋转。
在这项回顾性、非对照、干预性病例系列研究中,纳入了 2011 年 7 月至 2016 年 7 月期间接受原发性翼状胬肉手术的 98 例 98 只眼。采用该技术,从翼状胬肉组织本身获取移植物,不移植物旋转,并使用纤维蛋白胶将其粘附在裸露的巩膜缺损处。对翼状胬肉组织进行组织病理学分析,观察从翼状胬肉组织本身获得的薄结膜组织的形态和厚度。主要观察指标为复发率。研究的其他观察指标包括移植物回缩和移植物水肿。
平均年龄为 52 ± 10.04 岁。平均随访时间为 14 ± 8.24 个月。唯一的显著并发症是复发率为 4.08%(4 眼/98 眼)。最常见的次要结局是移植物水肿,发生率为 52.04%(51 眼/98 眼),无需任何干预即可消退。其他结局如移植物回缩,发生率为 32.65%。
从翼状胬肉组织本身获取结膜组织,而不移植物实际旋转,似乎是一种成功的技术,可降低青光眼滤过泡、青光眼疑似患者以及原发性双头翼状胬肉中治疗原发性翼状胬肉的复发率。